Onyx Healthcare Inc. (6569.TWO)
TWD 147.0
(0.0%)
TWD 147.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 350.49 Million | 161.79 Million | 17.12 Million | 191.1 Million | 376.45 Million |
| Net Income | 305 Million | 242.03 Million | 140.11 Million | 202.61 Million | 239.37 Million |
| Depreciation & Amortization | 24.09 Million | 26.83 Million | 27.03 Million | 30.22 Million | 27.6 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 3.59 Million | 16.96 Million | 11.61 Million | 4.71 Million | - |
| Change in working capital | 92.09 Million | -99.74 Million | -103.09 Million | -17.58 Million | 84.34 Million |
| Other non-cash items | 694 Thousand | -1.5 Million | 2.5 Million | -189 Thousand | 25.12 Million |
| Investing Cash Flow | -184.35 Million | -31.03 Million | -332.06 Million | -53.89 Million | -44.1 Million |
| Investments in PPE | -67.98 Million | -15.05 Million | -295.9 Million | -16.82 Million | -8.81 Million |
| Acquisitions | -14.38 Million | -15.8 Million | -14.58 Million | -27.95 Million | - |
| Investment purchases | -103.39 Million | -5.33 Million | -33.62 Million | -179 Thousand | -35.32 Million |
| Sales/Maturities of investments | - | 5.25 Million | - | 3.91 Million | 22 Thousand |
| Other Investing Activities | 1.4 Million | -344 Thousand | 12.03 Million | -12.84 Million | -35.28 Million |
| Financing Cash Flow | -128.53 Million | 6.03 Million | 109.89 Million | -148.91 Million | -141.84 Million |
| Debt repayment | -16.68 Million | -115.5 Million | -270.78 Million | - | -11.79 Million |
| Dividends payments | -166.3 Million | -133.04 Million | -151.3 Million | -132.04 Million | -130.04 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 28.29 Million | 263.1 Million | - | - | - |
| Other Financing Activities | -1.14 Million | - | 1.14 Million | - | -11.79 Million |
| Accounts receivables | 75.7 Million | - | - | - | 74.59 Million |
| Accounts payables | -37.8 Million | - | - | - | 9.16 Million |
| Inventory | 65.83 Million | -40.3 Million | -91.91 Million | -4.96 Million | -2.1 Million |
| Other working capital | -49.45 Million | - | - | - | 11.85 Million |
| Cash at beginning of period | 328.88 Million | 182.89 Million | 392.36 Million | 408.55 Million | 222.32 Million |
| Cash at end of period | 366.76 Million | 328.88 Million | 182.89 Million | 392.36 Million | 408.55 Million |
| Capital Expenditure | -67.98 Million | -15.05 Million | -295.9 Million | -16.82 Million | -8.81 Million |
| Effect of forex changes on cash | 282 Thousand | 9.2 Million | -4.43 Million | -4.49 Million | -4.27 Million |
| Net cash flow / Change in cash | 37.88 Million | 145.99 Million | -209.47 Million | -16.19 Million | 186.23 Million |
| Free Cash Flow | 282.51 Million | 146.74 Million | -278.77 Million | 174.28 Million | 367.63 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 41.14 Million | 56.99 Million | 305 Million | 85.26 Million | 79.33 Million | 80.22 Million |
| Depreciation & Amortization | 5.25 Million | 5.95 Million | 24.09 Million | 5.94 Million | 6.17 Million | 5.75 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 386 Thousand | 385 Thousand | 3.59 Million | 898 Thousand | 897 Thousand | 897 Thousand |
| Change in working capital | -43.36 Million | 86.84 Million | 92.09 Million | -27.55 Million | 107.93 Million | -856 Thousand |
| Other non-cash items | -680 Thousand | 427 Thousand | 694 Thousand | 396 Thousand | 657 Thousand | -616 Thousand |
| Investing Cash Flow | -3.09 Million | -66.97 Million | -184.35 Million | -15.91 Million | -96.66 Million | -43.74 Million |
| Investments in PPE | -1.39 Million | -1.38 Million | -67.98 Million | -2.26 Million | -3.64 Million | -43.74 Million |
| Acquisitions | - | - | -14.38 Million | - | -4.68 Million | - |
| Investment purchases | -1.7 Million | -71.18 Million | -103.39 Million | -13.85 Million | -89.53 Million | - |
| Sales/Maturities of investments | - | 5.59 Million | - | - | - | - |
| Other Investing Activities | -4000.00 | -7000.00 | 1.4 Million | 214 Thousand | 1.19 Million | -5000.00 |
| Financing Cash Flow | -2.18 Million | -3.19 Million | -128.53 Million | -3.7 Million | -118.9 Million | -865 Thousand |
| Debt repayment | -2.58 Million | -2.6 Million | -16.68 Million | -2.59 Million | -24.42 Million | -2.56 Million |
| Dividends payments | - | - | -166.3 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 994 Thousand | - | 28.29 Million | 1.1 Million | 24.08 Million | 3.09 Million |
| Other Financing Activities | 994 Thousand | - | -1.14 Million | - | - | - |
| Accounts receivables | -35.49 Million | - | - | - | - | - |
| Accounts payables | 6.6 Million | - | - | - | - | - |
| Inventory | -35.57 Million | -37.25 Million | 65.83 Million | 92.17 Million | -73.07 Million | 61.35 Million |
| Other working capital | 19.67 Million | - | - | - | - | - |
| Cash at beginning of period | 426.09 Million | 366.76 Million | 328.88 Million | 340.19 Million | 327.74 Million | 353.58 Million |
| Cash at end of period | 361.74 Million | 426.09 Million | 366.76 Million | 366.76 Million | 340.19 Million | 327.74 Million |
| Capital Expenditure | -1.39 Million | -1.38 Million | -67.98 Million | -2.26 Million | -3.64 Million | -43.74 Million |
| Effect of forex changes on cash | -4.2 Million | 4.59 Million | 282 Thousand | -5.47 Million | 4.46 Million | 1.71 Million |
| Net cash flow / Change in cash | -64.35 Million | 59.32 Million | 37.88 Million | 26.57 Million | 12.44 Million | -25.84 Million |
| Free Cash Flow | -56.26 Million | 123.5 Million | 282.51 Million | 49.4 Million | 219.91 Million | -26.69 Million |
FTC
6582
0IP1
SOBS
BRLA
PTBA